Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes

Modern Pathology

Volumn 16, Issue 9, 2003, Pages 920-929

  Starz, Hans ^a   Haas, Christian J ^a   Schulz, Gesa Maria ^a   Balda, Bernd Rüdiger ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

Melanoma; Metastasis; Nevocyte; Sentinel lymph node; Tyrosinase RT PCR

Indexed keywords

BETA 2 MICROGLOBULIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PARAFFIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; METASTASIS; MICROSCOPY; NEVUS CELL; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; STANDARD; TISSUE SECTION;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; MONOPHENOL MONOOXYGENASE; NEVUS; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0038220726     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000086074.55963.24     Document Type: Article

References (44)

1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137-43.
3. van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-70.
4. Bachter D, Balda BR, Vogt H, Büchels H. "Sentinel" lymphonodectomy with scintillation detector. A new strategy in treatment of malignant melanoma. Hautarzt 1996;47:754-8.
5. Thompson JF, Niewind P, Uren RF, Bosch CM, Howman-Giles R, Vrouenraets BC. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res 1997;7:500-6.
6. Starz H, Balda B-R. Sentinel lymphonodectomy and micromorphometric S-staging, a successful new strategy in the management of cutaneous malignancies. Giorn Ital Dermatol Venereol 2000;135:161-9.
7. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000;89:236-41.
8. Starz H, Bachter D, Balda B-R, et al. Qualitative and quantitative evaluation of sentinel lymph nodes in cutaneous malignancies. Nuklearmediziner 1999;22:253-60.
9. Starz H, Balda BR, Krämer KU, Büchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-21.
10. Wang X, Heller R, VanVoorhis N, Cruse CW, Glass F, Fenske N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
11. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-5.
12. Bieligk SC, Ghossein R, Bhattacharya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 1999;6:232-40.
13. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17:3238-44.
14. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637-42.
15. Hochberg M, Lotem M, Gimon Z, Shiloni E, Enk CD. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 2002;146:244-9.
16. Carson KF, Wen DR, Li PX, Lana AM, Bailly C, Morton DL, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
17. Starz H, Balda B-R, Büchels H. Sentinel-Lymphonodektomie bei malignen Melanomen. Eine vorläufige Bilanz aus histomorphologischer Sicht. In: Garbe C, Rassner G, editors. Dermatologie. Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Berlin: Springer; 1998. p. 274-7.
18. Cochran AJ, Starz H. Pathologic aspects. In: Cody HS III, editor. Sentinel lymph node biopsy. London: Martin Dunitz Ltd; 2002. p. 79-90.
19. Bachter D, Balda BR, Vogt H, Büchels H. Primary therapy of malignant melanomas: sentinel lymphadenectomy. Int J Dermatol 1998;37:278-82.
20. Fredricks DN, Relman DA. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 1999;26:198-200.
21. Stanta G, Schneider C. RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques 1991;11:304,306,308.
22. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
23. Oda Y, Rose I, Radig K, Wagemann W, Mittler U, Roessner A. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours. Virchows Arch 1997;430:99-105.
24. Cabañas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
25. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
26. Virchow R. Dritte Vorlesung. Allgemeine Physiologie der Geschwülste. In: Virchow R, editor. Die krankhaften Geschwülste. Berlin: Hirschwald; 1863. p. 33-56.
27. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg 1984;119:1067-72.
28. Sleeman JP. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 2000;157:55-81.
29. Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000;88:1484-91.
30. Cochran AJ. Prediction of outcome for patients with cutaneous melanoma. Pigment Cell Res 1997;10:162-7.
31. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
32. Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000;7:160-5.
33. Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484-9.
34. Lukowsky A, Bellmann B, Ringk A, Winter H, Audring H, Fenske S, et al. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction. J Invest Dermatol 1999;113:554-9.
35. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, de Weger RA, De Graaf PW, Tilanus MG, et al. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759-64.
36. Li W, Stall A, Shivers SC, Lin J, Haddad F, Messina J, et al. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 2000;231:795-803.
37. Palmieri G, Ascierto PA, Cossu A, Mozzillo N, Motti ML, Satriano SM, et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001;19:1437-43.
38. Bonin S, Niccolini B, Calacione R, Gambardella B, Geatti O, Stanta G, et al. Molecular analyses of sentinel lymph nodes: an open question. J Eur Acad Dermatol Venereol 2002;16:34-9.
39. Starz H, Balda BR, Bachter D, Büchels H, Vogt H. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas. Cancer 1999;85:199-207.
40. Düker I, Starz H, Bachter D, Balda BR. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 2001;202:225-9.
41. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification. Eur Urol 1999;36:595-600.
42. Levenback C. Gynecologic cancers. In: Cody HS III, editor. Sentinel lymph node biopsy. London: Martin Dunitz Ltd; 2002. p. 339-50.
43. Saha S, Bilchik A, Wiese D. Colorectal cancer. In: Cody HS III, editor. Sentinel lymph node biopsy. London: Martin Dunitz Ltd; 2002. p. 351-8.
44. Turner RR. Pathologic aspects. In: Cody HS III, editor. Sentinel lymph node biopsy. London: Martin Dunitz Ltd; 2002. p. 191-208.